Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1969 Jun;16(6):693–697.

The murine runting syndrome and neoplasia

D Keast
PMCID: PMC1409660  PMID: 4306783

Abstract

Malignant neoplasia occurred in mice runted by several treatments. The greatest incidence of neoplasia occurred following chronic and acute toxaemia induced by crude preparations of bacterial endotoxin from the animals' own gut flora. It is suggested that bacterial toxins may be more important in the induction of neoplasia in the murine runting syndrome than immunological mechanisms.

Full text

PDF
693

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. GORZYNSKI E. A., LUDERITZ O., NETER E., WESTPHAL O. The bacterial hemagglutination test for the demonstration of antibodies to Enterobacteriaceae. Ann N Y Acad Sci. 1956 Aug 10;66(1):141–156. doi: 10.1111/j.1749-6632.1956.tb40113.x. [DOI] [PubMed] [Google Scholar]
  2. Joske R. A., Leak P. J., Papadimitriou J. M., Stanley N. F., Walters M. N. Murine infection with reovirus. IV. Late chronic disease and the induction of lymphoma after reovirus type 3 infection. Br J Exp Pathol. 1966 Aug;47(4):337–346. [PMC free article] [PubMed] [Google Scholar]
  3. Keast D. A simple index for the measurement of the runting syndrome and its use in the study of the influence of the gut flora in its production. Immunology. 1968 Aug;15(2):237–245. [PMC free article] [PubMed] [Google Scholar]
  4. Keast D., Walters M. N. The pathology of murine runting and its modification by neomycin sulphate gavages. Immunology. 1968 Aug;15(2):247–262. [PMC free article] [PubMed] [Google Scholar]
  5. McBride R. A. Graft-versus-host reaction in lymphoid proliferation. Cancer Res. 1966 Jun;26(6):1135–1151. [PubMed] [Google Scholar]
  6. STANLEY N. F., DORMAN D. C., PONSFORD J. Studies on the pathogenesis of a hitherto undescribed virus (hepato-encephalomyelitis) producing unusual symptoms in suckling mice. Aust J Exp Biol Med Sci. 1953 Apr;31(2):147–159. doi: 10.1038/icb.1953.18. [DOI] [PubMed] [Google Scholar]
  7. STANLEY N. F., LEAK P. J., WALTERS M. N., JOSKE R. A. MURINE INFECTIONS WITH REOVIRUS. II. THE CHRONIC DISEASE FOLLOWING REOVIRUS TYPE 3 INFECTION. Br J Exp Pathol. 1964 Apr;45:142–149. [PMC free article] [PubMed] [Google Scholar]
  8. Stanley N. F., Walters N. M. Virus induction autoimmune disease and neoplasia. Lancet. 1966 Apr 30;1(7444):962–963. doi: 10.1016/s0140-6736(66)90956-1. [DOI] [PubMed] [Google Scholar]
  9. Walburg H. E., Jr, Cosgrove G. E., Upton A. C. Influence of microbial environment on development of myeloid leukemia in x-irradiated RFM mice. Int J Cancer. 1968 Jan 15;3(1):150–154. doi: 10.1002/ijc.2910030118. [DOI] [PubMed] [Google Scholar]
  10. Walford R. L., Hildemann W. H. Life span and lymphoma-incidence of mice injected at birth with spleen cells across a weak histocompatibility locus. Am J Pathol. 1965 Nov;47(5):713–721. [PMC free article] [PubMed] [Google Scholar]
  11. Walford R. L. Increased incidence of lymphoma after injections of mice with cells differing at weak histocompatibility loci. Science. 1966 Apr 1;152(3718):78–80. doi: 10.1126/science.152.3718.78. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES